Literature DB >> 32715602

Validation of online functional measures in cognitively impaired older adults.

Rachel L Nosheny1,2, Monica R Camacho2, Chengshi Jin3, John Neuhaus3, Diana Truran2, Derek Flenniken2, Miriam Ashford2, Maria C Carrillo4, Keith N Fargo4, James Hendrix4, Lucy Hanna5, Gil Rabinovici6,7, Paul Maruff8, R Scott Mackin1,2, Michael W Weiner2,7.   

Abstract

INTRODUCTION: Assessment of functional status is associated with risk of cognitive decline and diagnosis of dementia, and can be assessed by participants and study partners (SPs).
METHODS: In 770 older adults enrolled in the Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) study and the online Brain Health Registry (BHR), we estimated associations between online assessments and clinical variables related to Alzheimer's disease (AD) risk.
RESULTS: Worse online learning scores and SP-reported functional decline were associated with higher probability of AD dementia diagnosis and poor in-clinic cognitive assessment, and with higher odds of amyloid beta (Aβ) positivity when combined with participants' report of less decline. SP report of functional decline conferred predictive value independent of online cognitive assessments. Participants underreported decline compared to SPs. DISCUSSION: The results support the validity of online assessments and their greater utilization in healthcare and research settings. Online SP-reported functional decline is an indicator of dementia and AD risk.
© 2020 the Alzheimer's Association.

Entities:  

Keywords:  activities of daily living; amyloid beta; dementia; functional decline; internet-based registry; mild cognitive impairment; study partner; subjective cognitive decline

Year:  2020        PMID: 32715602      PMCID: PMC7544675          DOI: 10.1002/alz.12138

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  44 in total

1.  The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Marilyn S Albert; Steven T DeKosky; Dennis Dickson; Bruno Dubois; Howard H Feldman; Nick C Fox; Anthony Gamst; David M Holtzman; William J Jagust; Ronald C Petersen; Peter J Snyder; Maria C Carrillo; Bill Thies; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Regional cortical thinning and cerebrospinal biomarkers predict worsening daily functioning across the Alzheimer's disease spectrum.

Authors:  Gad A Marshall; Natacha Lorius; Joseph J Locascio; Bradley T Hyman; Dorene M Rentz; Keith A Johnson; Reisa A Sperling
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

3.  The AD8: a brief informant interview to detect dementia.

Authors:  J E Galvin; C M Roe; K K Powlishta; M A Coats; S J Muich; E Grant; J P Miller; M Storandt; J C Morris
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

4.  Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts.

Authors:  Sarah Tomaszewski Farias; Dan Mungas; Bruce R Reed; Danielle Harvey; Charles DeCarli
Journal:  Arch Neurol       Date:  2009-09

5.  Relationships between performance on the Cogstate Brief Battery, neurodegeneration, and Aβ accumulation in cognitively normal older adults and adults with MCI.

Authors:  Yen Ying Lim; Robert H Pietrzak; Pierrick Bourgeat; David Ames; Kathryn A Ellis; Alan Rembach; Karra Harrington; Olivier Salvado; Ralph N Martins; Peter J Snyder; Colin L Masters; Christopher C Rowe; Victor L Villemagne; Paul Maruff
Journal:  Arch Clin Neuropsychol       Date:  2014-12-02       Impact factor: 2.813

6.  Depressive Symptoms as a Predictor of Memory Complaints in the PRISM Sample.

Authors:  Jong-Sung Yoon; Neil Charness; Walter R Boot; Sara J Czaja; Wendy A Rogers
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2019-01-10       Impact factor: 4.077

7.  Subjective Evaluation of Mood and Cognitive Functions in a General Neurology Clinic: Patients versus Informants.

Authors:  Adolfo Jiménez-Huete; Antonio Del Barrio; Elena Riva; Pablo Campo; Rafael Toledano; Oriol Franch
Journal:  J Clin Neurol       Date:  2017-07       Impact factor: 3.077

8.  Study partner-reported decline identifies cognitive decline and dementia risk.

Authors:  Rachel L Nosheny; Chengshi Jin; John Neuhaus; Philip S Insel; Robert Scott Mackin; Michael W Weiner
Journal:  Ann Clin Transl Neurol       Date:  2019-11-13       Impact factor: 4.511

9.  Subjective cognitive decline and risk of MCI: The Mayo Clinic Study of Aging.

Authors:  Argonde C van Harten; Michelle M Mielke; Dana M Swenson-Dravis; Clinton E Hagen; Kelly K Edwards; Rosebud O Roberts; Yonas E Geda; David S Knopman; Ronald C Petersen
Journal:  Neurology       Date:  2018-06-29       Impact factor: 11.800

10.  Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer's disease.

Authors:  Omar A Halawa; Jennifer R Gatchel; Rebecca E Amariglio; Dorene M Rentz; Reisa A Sperling; Keith A Johnson; Gad A Marshall
Journal:  Alzheimers Res Ther       Date:  2019-01-31       Impact factor: 6.982

View more
  6 in total

1.  Predicting amyloid status using self-report information from an online research and recruitment registry: The Brain Health Registry.

Authors:  Miriam T Ashford; John Neuhaus; Chengshi Jin; Monica R Camacho; Juliet Fockler; Diana Truran; R Scott Mackin; Gil D Rabinovici; Michael W Weiner; Rachel L Nosheny
Journal:  Alzheimers Dement (Amst)       Date:  2020-09-24

Review 2.  Early-stage Alzheimer disease: getting trial-ready.

Authors:  Paul S Aisen; Gustavo A Jimenez-Maggiora; Michael S Rafii; Sarah Walter; Rema Raman
Journal:  Nat Rev Neurol       Date:  2022-04-04       Impact factor: 44.711

3.  Development and implementation of an electronic Clinical Dementia Rating and Financial Capacity Instrument-Short Form.

Authors:  Taylor Howell; Shilpa Gummadi; Chau Bui; Jessica Santhakumar; Kristen Knight; Erik D Roberson; Daniel Marson; Carol Chambless; Adam Gersteneker; Roy Martin; Richard Kennedy; Yue Zhang; John C Morris; Krista L Moulder; Connie Mayo; Maria Carroll; Yan Li; Ronald C Petersen; Nikki H Stricker; Rachel L Nosheny; Scott Mackin; Michael W Weiner
Journal:  Alzheimers Dement (Amst)       Date:  2022-07-24

4.  The role of dyadic cognitive report and subjective cognitive decline in early ADRD clinical research and trials: Current knowledge, gaps, and recommendations.

Authors:  Rachel L Nosheny; Rebecca Amariglio; Sietske A M Sikkes; Carol Van Hulle; Maria Aparecida Camargos Bicalho; N Maritza Dowling; Sonia Maria Dozzi Brucki; Zahinoor Ismail; Kensaku Kasuga; Elizabeth Kuhn; Katya Numbers; Anna Aaronson; Davide Vito Moretti; Arturo X Pereiro; Gonzalo Sánchez-Benavides; Allis F Sellek Rodríguez; Prabitha Urwyler; Kristina Zawaly
Journal:  Alzheimers Dement (N Y)       Date:  2022-10-04

5.  Machine learning approaches to predicting amyloid status using data from an online research and recruitment registry: The Brain Health Registry.

Authors:  Jack Albright; Miriam T Ashford; Chengshi Jin; John Neuhaus; Gil D Rabinovici; Diana Truran; Paul Maruff; R Scott Mackin; Rachel L Nosheny; Michael W Weiner
Journal:  Alzheimers Dement (Amst)       Date:  2021-06-09

6.  Everyday Functioning in a Community-Based Volunteer Population: Differences Between Participant- and Study Partner-Report.

Authors:  Merike Verrijp; Mark A Dubbelman; Leonie N C Visser; Roos J Jutten; Elke W Nijhuis; Marissa D Zwan; Hein P J van Hout; Philip Scheltens; Wiesje M van der Flier; Sietske A M Sikkes
Journal:  Front Aging Neurosci       Date:  2022-01-05       Impact factor: 5.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.